First Time Loading...

Novo Nordisk A/S
CSE:NOVO B

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
CSE:NOVO B
Watchlist
Price: 850.6 DKK -2.58% Market Closed
Updated: May 5, 2024

Novo Nordisk A/S
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Novo Nordisk A/S
Income from Continuing Operations Peer Comparison

Comparables:
HLUN A
ALK B

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Novo Nordisk A/S
CSE:NOVO B
Income from Continuing Operations
kr83.7B
CAGR 3-Years
26%
CAGR 5-Years
17%
CAGR 10-Years
13%
H Lundbeck A/S
CSE:HLUN A
Income from Continuing Operations
kr2.3B
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Income from Continuing Operations
kr486m
CAGR 3-Years
169%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Novo Nordisk A/S's Income from Continuing Operations?
Income from Continuing Operations
83.7B DKK

Based on the financial report for Dec 31, 2023, Novo Nordisk A/S's Income from Continuing Operations amounts to 83.7B DKK.

What is Novo Nordisk A/S's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
13%

Over the last year, the Income from Continuing Operations growth was 51%. The average annual Income from Continuing Operations growth rates for Novo Nordisk A/S have been 26% over the past three years , 17% over the past five years , and 13% over the past ten years .